Corient Private Wealth’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.41M | Buy |
89,396
+31,817
| +55% | +$2.64M | 0.01% | 649 |
|
|
2025
Q1 | $4.67M | Sell |
57,579
-28,167
| -33% | -$2.28M | 0.01% | 701 |
|
|
2024
Q4 | $7.46M | Sell |
85,746
-20,259
| -19% | -$1.76M | 0.01% | 593 |
|
|
2024
Q3 | $10.5M | Sell |
106,005
-17,909
| -14% | -$1.77M | 0.02% | 535 |
|
|
2024
Q2 | $11.5M | Sell |
123,914
-19,481
| -14% | -$1.81M | 0.02% | 499 |
|
|
2024
Q1 | $13.6M | Buy |
143,395
+17,218
| +14% | +$1.63M | 0.02% | 461 |
|
|
2023
Q4 | $11.3M | Buy |
126,177
+22,902
| +22% | +$2.04M | 0.02% | 489 |
|
|
2023
Q3 | $7.54M | Sell |
103,275
-12,259
| -11% | -$895K | 0.02% | 541 |
|
|
2023
Q2 | $9.61M | Buy |
115,534
+31,735
| +38% | +$2.64M | 0.02% | 482 |
|
|
2023
Q1 | $6.39M | Buy |
83,799
+81,043
| +2,941% | +$6.18M | 0.02% | 526 |
|
|
2022
Q4 | $229K | Buy |
+2,756
| New | +$229K | ﹤0.01% | 1438 |
|